BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11810479)

  • 1. Appearance of denuded hepatic stellate cells and their subsequent myofibroblast-like transformation during the early stage of biliary fibrosis in the rat.
    Tao LH; Enzan H; Hayashi Y; Miyazaki E; Saibara T; Hiroi M; Toi M; Kuroda N; Naruse K; Jin YL; Guo LM
    Med Electron Microsc; 2000; 33(4):217-30. PubMed ID: 11810479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
    Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
    Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat.
    Desmoulière A; Darby I; Costa AM; Raccurt M; Tuchweber B; Sommer P; Gabbiani G
    Lab Invest; 1997 Jun; 76(6):765-78. PubMed ID: 9194853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histogenesis of bile duct-like cells proliferating during ethionine hepatocarcinogenesis. Evidence for a biliary epithelial nature of oval cells.
    Lenzi R; Liu MH; Tarsetti F; Slott PA; Alpini G; Zhai WR; Paronetto F; Lenzen R; Tavoloni N
    Lab Invest; 1992 Mar; 66(3):390-402. PubMed ID: 1538592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
    Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
    BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of extracellular matrix genes in cultured hepatic oval cells: an origin of hepatic stellate cells through transforming growth factor beta?
    Wang P; Liu T; Cong M; Wu X; Bai Y; Yin C; An W; Wang B; Jia J; You H
    Liver Int; 2009 Apr; 29(4):575-84. PubMed ID: 19323784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat.
    Saperstein LA; Jirtle RL; Farouk M; Thompson HJ; Chung KS; Meyers WC
    Hepatology; 1994 Feb; 19(2):412-7. PubMed ID: 8294098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations.
    Tannuri AC; Coelho MC; de Oliveira Gonçalves J; Santos MM; Ferraz da Silva LF; Bendit I; Tannuri U
    J Pediatr Surg; 2012 Mar; 47(3):513-22. PubMed ID: 22424347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats.
    Zhong Z; Froh M; Lehnert M; Schoonhoven R; Yang L; Lind H; Lemasters JJ; Thurman RG
    Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1004-13. PubMed ID: 12791596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in bile ducts and peribiliary microcirculation in rats after common bile duct ligation.
    Nakano S; Haratake J; Hashimoto H
    Hepatology; 1995 May; 21(5):1380-6. PubMed ID: 7737645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury.
    Hines JE; Johnson SJ; Burt AD
    Am J Pathol; 1993 Feb; 142(2):511-8. PubMed ID: 8434646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell proliferation activity of proliferating bile duct after bile duct ligation in rats.
    Yoshioka K; Mori A; Taniguchi K; Mutoh K
    Vet Pathol; 2005 May; 42(3):382-5. PubMed ID: 15872390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
    Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
    Camino AM; Atorrasagasti C; Maccio D; Prada F; Salvatierra E; Rizzo M; Alaniz L; Aquino JB; Podhajcer OL; Silva M; Mazzolini G
    J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
    Bataller R; Gäbele E; Parsons CJ; Morris T; Yang L; Schoonhoven R; Brenner DA; Rippe RA
    Hepatology; 2005 May; 41(5):1046-55. PubMed ID: 15841463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
    Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
    J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices.
    Guyot C; Combe C; Balabaud C; Bioulac-Sage P; Desmoulière A
    J Hepatol; 2007 Jan; 46(1):142-50. PubMed ID: 17069927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways.
    Bridle KR; Popa C; Morgan ML; Sobbe AL; Clouston AD; Fletcher LM; Crawford DH
    Liver Transpl; 2009 Oct; 15(10):1315-24. PubMed ID: 19790156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.